Risk Factors, Molecular Epidemiology, and Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection for Hospital-Acquired Pneumonia: A Matched Case-Control Study in Eastern China During 2015–2017
Authors:
- 2 July 2020
- journal article
- research article
- Published by SAGE Publications in Microbial Drug Resistance
- Vol. 27 (2) , 204-211
Abstract
This study was conducted to acknowledge microbiological and clinical characteristics of hospital-acquired pneumonia (HAP) caused by carbapenem-resistant Klebsiella pneumoniae (CRKP). A retrospective, 1:1 matched (age, gender, specimen source, and ward) case-control study was conducted during 2015–2017 in a tertiary teaching hospital in Anhui, China. Multivariate logistic regression analysis demonstrated that prior central venous catheter use, sputum suction, continuous renal replacement therapy, and exposure to fluroquinolones were independent risk factors for the morbidity of CRKP infection for HAP. Treatment failure for infection was an independent risk factor for crude in-hospital mortality, while the use of fluroquinolones may improve the effective treatment for infection ( p = 0.040). Among 74 CRKP strains, 85.1% of them were positive for the production of KPC-2, and one of them was detected for co-harboring bla KPC-2 and bla IMP-38-like . Separately, sequence type (ST) 11 (81.1%) was the predominant ST in this study, and ST11 CRKP isolates were related with higher detection rate of bla KPC-2 and lower resistance rate to trimethoprim/sulfamethoxazole when compared with non-ST11 ones. Moreover, resistance to carbapenem was associated with higher mortality (35.1%) and hospitalization costs for HAP patients with K. pneumoniae infection. Invasive procedures may increase the morbidity of CRKP infection for HAP. Prior exposure to fluroquinolones is associated with the development of resistance, but as a targeted treatment it may be effective.Keywords
This publication has 27 references indexed in Scilit:
- Current Status and Trends of Antibacterial Resistance in ChinaClinical Infectious Diseases, 2018
- Antimicrobial Resistance and Respiratory InfectionsChest, 2018
- Etiological Trends and Patterns of Antimicrobial Resistance in Respiratory InfectionsThe Open Microbiology Journal, 2018
- Risk Factors for Carbapenem-Resistant Klebsiella pneumoniae Infection: A Meta-AnalysisMicrobial Drug Resistance, 2018
- Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection MethodsFrontiers in Microbiology, 2016
- Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial DominanceAntimicrobial Agents and Chemotherapy, 2015
- Risk factors for carbapenem-resistantKlebsiella pneumoniaeinfection/colonization and predictors of mortality: a retrospective studyPathogens and Global Health, 2015
- Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013Eurosurveillance, 2013
- Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global DimensionsClinical Microbiology Reviews, 2012
- Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum -lactamases: a systematic review and meta-analysisJournal of Antimicrobial Chemotherapy, 2012